These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20336454

  • 21. Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
    Fendler WP, Chalkidis RP, Ilhan H, Knösel T, Herrmann K, Issels RD, Bartenstein P, Cyran CC, Lindner LH, Hacker M.
    Eur Radiol; 2015 Aug; 25(8):2214-21. PubMed ID: 25693667
    [Abstract] [Full Text] [Related]

  • 22. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [Abstract] [Full Text] [Related]

  • 23. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
    Dose Schwarz J, Bader M, Jenicke L, Hemminger G, Jänicke F, Avril N.
    J Nucl Med; 2005 Jul; 46(7):1144-50. PubMed ID: 16000283
    [Abstract] [Full Text] [Related]

  • 24. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
    Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ.
    Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
    Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti PS.
    Clin Nucl Med; 2008 Jan; 33(1):8-13. PubMed ID: 18097248
    [Abstract] [Full Text] [Related]

  • 27. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
    Dimitrakopoulou-Strauss A, Pan L, Strauss LG.
    Cancer Imaging; 2012 Sep 28; 12(1):283-9. PubMed ID: 23033440
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y.
    Eur J Nucl Med Mol Imaging; 2003 Jan 28; 30(1):63-71. PubMed ID: 12483411
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
    Hamada K, Tomita Y, Inoue A, Fujimoto T, Hashimoto N, Myoui A, Yoshikawa H, Hatazawa J.
    Ann Nucl Med; 2009 Jan 28; 23(1):89-95. PubMed ID: 19205843
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[(18)F]fluoro-D-glucose ( (18)F-FDG) and (18)F-fluoride.
    Cheng C, Alt V, Dimitrakopoulou-Strauss A, Pan L, Thormann U, Schnettler R, Weber K, Strauss LG.
    Mol Imaging Biol; 2013 Jun 28; 15(3):336-44. PubMed ID: 22965489
    [Abstract] [Full Text] [Related]

  • 36. The impact of 18F-FDG PET on initial staging and therapy planning of pediatric soft-tissue sarcoma patients.
    Elmanzalawy A, Vali R, Chavhan GB, Gupta AA, Omarkhail Y, Amirabadi A, Shammas A.
    Pediatr Radiol; 2020 Feb 28; 50(2):252-260. PubMed ID: 31628508
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model.
    Dimitrakopoulou-Strauss A, Hohenberger P, Pan L, Kasper B, Roumia S, Strauss LG.
    Clin Nucl Med; 2012 Oct 28; 37(10):943-8. PubMed ID: 22899201
    [Abstract] [Full Text] [Related]

  • 40. Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
    Favinger JL, Hippe DS, Davidson DJ, Elojeimy S, Roth ES, Lindberg AW, Ha AS.
    Acad Radiol; 2018 Apr 28; 25(4):470-475. PubMed ID: 29273189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.